- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
May 7th, 2007
NanoViricides Inc. saw its stock jump 8 percent Monday after the company announced positive results of recent tests of its antiviral drug designed to treat bird flu.
The stock, which trades on the Pink Sheets market as NNVC.pk, rose 9 cents to close at $1.19 a share Monday.
NanoViricides, based at 135 Wood St., recently carried out in vitro testing of its FluCide-HP — an antiviral drug delivered by nanotechnology — in Vietnam.
|Related News Press|
Nanometrics Announces Upcoming Investor Events May 10th, 2016
Aspen Aerogels to Present at the 28th Annual ROTH Conference March 14th, 2016
Simple attraction: Researchers control protein release from nanoparticles without encapsulation: U of T Engineering discovery stands to improve reliability and fabrication process for treatments to conditions such as spinal cord damage and stroke May 28th, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Are humans the new supercomputer?Today, people of all backgrounds can contribute to solving serious scientific problems by playing computer games. A Danish research group has extended the limits of quantum physics calculations and simultaneously blurred the boundaries between mac April 14th, 2016
UCLA nanoscientists engage shoppers in fun conversations March 8th, 2016
Risk Analysis Publishes Non-Animal Strategy to Assess Nanomaterials February 24th, 2016